University Hospital Rigshospitalet
Welcome,         Profile    Billing    Logout  
 12 Trials 
20 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gustafsson, Finn
ARETHA, NCT06671990: The CardioMEMS Vericiguat Heart Failure Trial

Not yet recruiting
4
17
NA
Vericiguat, Placebo
Finn Gustafsson, Aarhus University Hospital
Heart Failure, Pulmonary Arterial Hypertension
12/24
01/26
SAINTS B, NCT05284955: Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study

Recruiting
4
60
Europe
CardioMEMS HF System, Standard heart failure medical therapy
Finn Gustafsson, Novo Nordisk A/S, Abbott
Advanced Heart Failure, Heart Failure With Reduced Ejection Fraction
12/25
12/25
DANHEART, NCT03514108 / 2015-002150-12: (H-HeFT and Met-HeFT)

Recruiting
4
1500
Europe
Hydralazine Isosorbide Dinitrate, BiDil, Placebo Oral Tablet, Metformin Hydrochloride
Henrik Wiggers, Danish Heart Foundation, Danish Council for Independent Research, The Danish Regions: Foundation for Medical Research, The Novo Nordisk Foundation, The Aase og Ejnar Danielsen Foundation
Heart Failure, Diabetes
12/26
12/26
MYTHS, NCT05150704: - MYocarditis THerapy With Steroids

Recruiting
3
288
Europe, US, RoW
Methylprednisolone, saline solution
Niguarda Hospital, Ministry of Health, Italy, Istituto Di Ricerche Farmacologiche Mario Negri, University of Milano Bicocca, Regione Lombardia
Myocarditis Acute
03/28
12/28
ARNiAMI, NCT04149990: Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

Terminated
2
51
Europe
Entresto Pill, Valsartan+ sacubitril
Jacob Moller, Danish Heart Foundation, Odense University Hospital, Rigshospitalet, Denmark
Myocardial Infarction, Diastolic Dysfunction
07/22
06/23
Act-VAD, NCT04732039: Daily Life Activities in Patients Treated With Continuous-Flow Left Ventricular Assist Devices

Recruiting
N/A
50
Europe
Measurement of peak oxygen uptake
Rigshospitalet, Denmark
Left Ventricular Failure, Unspecified
12/22
12/22
CuDOSIS, NCT06131112: Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis

Recruiting
N/A
76
Europe
64Cu-DOTATATE PET/CT scan
Rigshospitalet, Denmark
Cardiac Sarcoidosis
01/26
01/27
SAINTS-A, NCT05299879: Screening for Advanced Heart Failure IN Stable ouTpatientS - The SAINTS Study

Recruiting
N/A
400
Europe
Cardiopulmonary exercise test, NT-proBNP, Echocardiography, 6 minute walk test, Right heart catheterization
Rigshospitalet, Denmark, Novo Nordisk A/S
Heart Failure With Reduced Ejection Fraction
12/25
12/25
PRO-VAD, NCT04423562: PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist Devices

Recruiting
N/A
500
Europe
No intervention
Rigshospitalet, Denmark
Left Ventricular Assist Device, Prognosis, Advanced Heart Failure
12/22
12/22
Nysom, Karsten
BIOMEDE 2, NCT05476939: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

Recruiting
3
409
Europe
Everolimus, VOTUBIA, AFINITOR, ONC201, Radiotherapy
Gustave Roussy, Cancer Campus, Grand Paris, Chimerix, Innovative Therapies For Children with Cancer Consortium, Ministry of Health, France
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant
09/28
09/31
NIVO-ALCL, NCT03703050 / 2018-001447-31: Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2)

Active, not recruiting
2
45
Europe
Nivolumab cohort 1, OpDIVO, Nivolumab cohort 2, opdivo
Gustave Roussy, Cancer Campus, Grand Paris
Relapsing/Refractory ALK+ Anaplastic Large Cell Lymphoma
06/25
09/25
NCT06413706: A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

Recruiting
2
45
Europe, Japan, US, RoW
Abemaciclib, LY2835219, Temozolomide
Eli Lilly and Company
Glioma
07/27
02/28
MEMMAT, NCT01356290 / 2010-023691-33: Antiangiogenic Therapy for Children with Recurrent Medulloblastoma, Ependymoma and ATRT

Recruiting
2
100
Europe, US
Bevacizumab, Avastin, Thalidomide, Celecoxib, Fenofibric acid, Etoposide, Cyclophosphamide, Etoposide phosphate, Cytarabine
Medical University of Vienna
Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent
04/30
04/30
REGO-EWING, NCT05830084 / 2022-002874-10: Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma

Recruiting
1
24
Europe, RoW
regorafenib tablet
Gustave Roussy, Cancer Campus, Grand Paris, Bayer
Bone Cancer
06/26
06/26
NCT02300766: Cerebellar Mutism Syndrome Study

Recruiting
N/A
1000
Europe, RoW
Rigshospitalet, Denmark, Odense University Hospital, Aarhus University Hospital, Aalborg University Hospital, Technical University of Denmark, Karolinska University Hospital, Skane University Hospital, University Hospital, Linkoeping, Uppsala University Hospital, Sahlgrenska University Hospital, Sweden, University Hospital, Umeå, Oslo University Hospital, Trondheim University Hospital, Haukeland University Hospital, University Hospital of North Norway, Helsinki University Central Hospital, Tampere University Hospital, Kuopio University Hospital, Turku University Hospital, Oulu University Hospital, Radboud University Medical Center, Liverpool University Hospitals NHS Foundation Trust, Great Ormond Street Hospital for Children NHS Foundation Trust, Nottingham University Hospitals NHS Trust, University Hospital Birmingham, University Hospitals Bristol and Weston NHS Foundation Trust, Royal Infirmary of Edinburgh, South Glasgow University Hospitals NHS Trust, University Hospital Tuebingen, Medical University of Vienna, Ospedale Pediatrico Bambin Gesù, Motol University Hospital, University of Leipzig Medical Center, Universitaire Ziekenhuizen KU Leuven, Queen Fabiola Children's University Hospital, Cliniques universitaires Saint-Luc, University Hospital, Ghent, Hospital De La Citadelle, CHC MontLégia, University Hospital, Antwerp
Infratentorial Neoplasms, Mutism
12/28
12/28
Gamper, Agnes
MEMMAT, NCT01356290 / 2010-023691-33: Antiangiogenic Therapy for Children with Recurrent Medulloblastoma, Ependymoma and ATRT

Recruiting
2
100
Europe, US
Bevacizumab, Avastin, Thalidomide, Celecoxib, Fenofibric acid, Etoposide, Cyclophosphamide, Etoposide phosphate, Cytarabine
Medical University of Vienna
Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent
04/30
04/30
Benndorf, Goetz
Tension, NCT03094715: Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window

Terminated
N/A
253
Europe, Canada, RoW
Thrombectomy, Mechanical thrombectomy, Best medical care, Control group
University Hospital Heidelberg, Karolinska University Hospital, Eppdata GmbH Hamburg, Germany, Aarhus University Hospital, Medical University Innsbruck, Groupe Hospitalier Pitie-Salpetriere, Oslo University Hospital, University Hospital, Martin, Charles University, Czech Republic, Hospices Civils de Lyon, CHU de Reims, Epidemiological and Clinical Research Information Network, STROKE ALLIANCE FOR EUROPE, International Consortium for Health Outcome Measurement, Inc., Europan Society for Minimally Invasive Neurological Therapy, Universitätsklinikum Hamburg-Eppendorf
Stroke, Acute, Cerebral Stroke, Cerebrovascular Stroke, Apoplexy; Brain
05/23
11/23
Hjalgrim, Lisa L
FaR-RMS, NCT04625907 / 2018-000515-24: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

Recruiting
1/2
1672
Europe, RoW
Irinotecan, Actinomycin D, Dactinomycin, Doxorubicin, Ifosfamide, Vincristine, Vinorelbine, Cyclophosphamide, Temozolomide, radiotherapy, Regorafenib
University of Birmingham
Rhabdomyosarcoma
06/30
06/30
MyBrain, NCT05840575: Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

Recruiting
N/A
100
Europe
Rigshospitalet, Denmark
Chemotherapy-Related Cognitive Impairment, Chemotherapeutic Toxicity, Chemo-brain, Cancer, Childhood Cancer, Hodgkin Lymphoma, Non Hodgkin Lymphoma, Testicular Cancer, Sarcoma, Leukemia
03/27
03/27
Wendtland, Pernille
FaR-RMS, NCT04625907 / 2018-000515-24: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

Recruiting
1/2
1672
Europe, RoW
Irinotecan, Actinomycin D, Dactinomycin, Doxorubicin, Ifosfamide, Vincristine, Vinorelbine, Cyclophosphamide, Temozolomide, radiotherapy, Regorafenib
University of Birmingham
Rhabdomyosarcoma
06/30
06/30

Download Options